FTV · Fortive Corp - Financials

Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.

Price · FTV

1Y 3Y 5Y Max

Annual Quarterly

Income Statement

Line item	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Revenue	$4.16B	$6.23B	$6.07B	$5.83B	$5.25B	$4.63B
Cost of Revenue	$1.52B	$2.50B	$2.47B	$2.46B	$2.25B	$2.03B
Gross Profit	$2.64B	$3.73B	$3.59B	$3.36B	$3.01B	$2.61B
R&D	$259.20M	$414.00M	$397.80M	$401.50M	$354.80M	$320.70M
SG&A	$1.66B	$2.17B	$2.06B	$1.96B	$1.84B	$1.75B
Total Operating Expenses	($1.92B)	($2.59B)	-	-	-	-
D&A	$437.60M	$543.90M	$456.80M	$465.60M	$395.50M	$384.00M
Operating Income	$720.20M	$1.21B	$1.13B	$987.40M	$812.80M	$539.40M
Interest Expense	($120.50M)	($152.80M)	$123.50M	$98.30M	$103.20M	$148.50M
Income Tax	$69.50M	$136.70M	$125.00M	$118.30M	$63.30M	$55.50M
Net Income	$579.20M	$832.90M	$865.80M	$755.20M	$608.40M	$1.54B
EPS - Basic	$1.74	$1.80	$1.85	$1.60	$1.24	$3.45
EPS - Diluted	$1.73	$1.78	$1.83	$1.58	$1.23	$3.38

Balance Sheet

Line item	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Cash & Equivalents	$375.50M	$813.30M	$1.89B	$709.20M	$819.30M	$1.82B
Accounts Receivable	$683.60M	$945.40M	$960.80M	$958.50M	$930.20M	$810.30M
Inventory	$291.80M	$544.80M	$536.90M	$536.70M	$512.70M	$455.50M
Accounts Payable	$436.40M	$677.40M	$608.60M	$623.00M	$557.90M	$480.80M
Current Assets	$1.61B	$2.59B	$3.67B	$2.48B	$2.51B	$4.45B
Total Assets	$11.74B	$17.02B	$16.91B	$15.89B	$16.47B	$16.05B
Current Liabilities	$2.25B	$2.24B	$1.79B	$2.73B	$3.71B	$2.86B
Long-term Debt	$2.31B	$3.33B	$3.65B	$2.25B	$1.81B	$2.83B
Total Liabilities	-	-	-	-	-	-
Stockholders' Equity	$6.45B	$10.19B	$10.32B	$9.68B	$9.51B	$8.96B
Retained Earnings	$5.43B	$8.23B	$7.51B	$6.74B	$6.02B	$5.55B

Cash Flow

Line item	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Operating Cash Flow	$1.08B	$1.53B	$1.35B	$1.30B	$961.10M	$1.44B
Investing Cash Flow	($135.40M)	($1.80B)	($195.40M)	($102.50M)	($2.62B)	($148.40M)
Financing Cash Flow	($1.39B)	($792.70M)	$32.30M	($1.27B)	$652.00M	($696.10M)
CapEx	$105.10M	$120.40M	$107.80M	$95.80M	$50.00M	$75.70M
Free Cash Flow	$978.10M	$1.41B	$1.25B	$1.21B	$911.10M	$1.36B

Ratios

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Profitability
Gross margin	63.5%	59.9%	59.3%	57.7%	57.2%	56.3%
Operating margin	17.3%	19.4%	18.7%	16.9%	15.5%	11.6%
EBITDA margin	27.8%	28.1%	26.2%	24.9%	23.0%	19.9%
Net margin	13.9%	13.4%	14.3%	13.0%	11.6%	33.3%
Free cash flow margin	23.5%	22.6%	20.5%	20.7%	17.3%	29.4%
FCF / Net income	1.69	1.69	1.44	1.60	1.50	0.88
R&D / Revenue	6.2%	6.6%	6.6%	6.9%	6.8%	6.9%
SG&A / Revenue	40.0%	34.9%	34.0%	33.6%	35.0%	37.7%
Effective tax rate	10.7%	14.1%	12.6%	13.5%	9.4%	3.5%
Return on assets	4.9%	4.9%	5.1%	4.8%	3.7%	9.6%
Return on equity	9.0%	8.2%	8.4%	7.8%	6.4%	17.2%
Return on invested capital	7.3%	7.7%	7.1%	7.2%	6.5%	4.4%
Liquidity
Current ratio	0.71	1.16	2.05	0.91	0.68	1.55
Quick ratio	0.58	0.91	1.75	0.71	0.54	1.40
Cash ratio	0.17	0.36	1.05	0.26	0.22	0.64
Leverage
Debt / Equity	0.36	0.33	0.35	0.23	0.19	0.32
Debt / Assets	0.20	0.20	0.22	0.14	0.11	0.18
Debt / EBITDA	1.99	1.90	2.29	1.55	1.50	3.07
Interest coverage	-6.0x	-7.9x	9.2x	10.0x	7.9x	3.6x
Equity multiplier	1.82	1.67	1.64	1.64	1.73	1.79
Liabilities / Assets	-	-	-	-	-	-
Efficiency
Asset turnover	0.35	0.37	0.36	0.37	0.32	0.29
Inventory turnover	5.20	4.59	4.60	4.59	4.38	4.45
Days sales outstanding	60d	55d	58d	60d	65d	64d
Days inventory outstanding	70d	80d	79d	80d	83d	82d
Days payable outstanding	105d	99d	90d	92d	91d	87d
Cash conversion cycle	25d	36d	47d	47d	57d	59d
Valuation
P / E	31.9x	31.8x	30.3x	30.6x	46.8x	15.8x
P / B	2.9x	2.0x	1.9x	1.8x	2.1x	2.1x
P / S	4.4x	3.2x	3.3x	3.0x	3.9x	4.1x
EV / EBITDA	17.6x	12.8x	13.5x	13.1x	17.6x	21.8x
Growth
Revenue growth (YoY)	-33.3%	2.7%	4.1%	10.9%	13.4%	-36.7%
Revenue CAGR (3y)	-10.6%	5.8%	9.4%	-7.3%	-0.8%	-11.4%
Revenue CAGR (5y)	-2.1%	-3.2%	2.4%	-2.6%	-3.3%	-
Gross profit growth (YoY)	-29.2%	3.8%	6.9%	11.8%	15.3%	-29.1%
Operating income growth (YoY)	-40.3%	6.4%	14.8%	21.5%	50.7%	-46.3%
Net income growth (YoY)	-30.5%	-3.8%	14.6%	24.1%	-60.6%	130.5%
EPS growth (YoY)	-2.7%	-2.9%	15.7%	28.8%	-63.7%	71.8%
EPS CAGR (3y)	3.0%	13.1%	-18.5%	-7.0%	-46.9%	4.6%
EPS CAGR (5y)	-12.6%	-2.0%	-25.9%	-11.8%	-13.3%	-
FCF growth (YoY)	-30.5%	12.9%	3.2%	32.5%	-33.1%	17.4%
FCF CAGR (5y)	-6.4%	3.9%	0.2%	3.0%	-2.0%	-
Book value growth (YoY)	-36.7%	-1.3%	6.6%	1.8%	6.1%	21.4%

Sales by segment

From XBRL dimensional facts in the 10-K period ending 2025-12-31.

Business segments

$4.16B total

Intelligent Operating Solutions$2.86B · 68.7%

Advanced Healthcare Solutions$1.30B · 31.3%

Product / service

$4.16B total

Product$3.34B · 80.3%

Service$817.80M · 19.7%

Geographic

$4.16B total

North America$2.49B · 59.9%

Asia Pacific$730.10M · 17.6%

EMEA$725.80M · 17.5%

Latin America$212.10M · 5.1%

Stability scores

Piotroski F-score

FY 2025 · 9-point quality

7/9

Strong

✓Net income positive
✓Operating cash flow positive
✓ROA improved YoY
✓Cash flow > net income
✓Long-term debt decreased
✗Current ratio improved
✓No share dilution
✓Gross margin improved
✗Asset turnover improved

Peer comparison

Same SIC group: Industrial Instruments For Measurement, Display, and Control

Company	Revenue (last FY)	Net margin	ROE
DHR	$24.57B	14.7%	6.9%
AME	$7.40B	20.0%	13.9%
KEYS	-	-	-
MKSI	$3.93B	7.5%	10.8%
SENS	$35.26M	-196.0%	-113.2%

Comparing Fortive Corp against the 5 most active filers in the same SIC group.

Dividends

$0.18/share trailing 12 months · -25.4% YoY

Ex-date	Per share
Mar 13, 2026	$0.0600
Nov 28, 2025	$0.0600
Sep 12, 2025	$0.0600
May 30, 2025	$0.0603
Feb 28, 2025	$0.0603
Nov 29, 2024	$0.0603
Sep 13, 2024	$0.0603
May 31, 2024	$0.0603
Feb 22, 2024	$0.0603
Nov 22, 2023	$0.0603
Aug 31, 2023	$0.0528
May 25, 2023	$0.0528
Feb 23, 2023	$0.0528
Nov 29, 2022	$0.0528
Aug 30, 2022	$0.0528
May 26, 2022	$0.0528
Feb 24, 2022	$0.0528
Nov 24, 2021	$0.0528
Sep 9, 2021	$0.0528
May 27, 2021	$0.0528
Feb 25, 2021	$0.0528
Nov 25, 2020	$0.0528
Aug 27, 2020	$0.0441
May 28, 2020	$0.0441